HOME ABOUT CONTACT PREVIOUS ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Molecular Marvel       » Biogas beats Bioethanol       » Brain 'switch' can Turn off Drug Addiction (Eye on China)       » Novel Imaging Technology REFI takes Clinicians closer to detecting Stage 0 Tumour Lesions (Eye on China)      
EYE ON CHINA
Zhifei Biological鈥檚 vaccine approved for clinical test
Chongqing Zhifei Biological Product Co., Ltd. got the approval documents for clinical test of its Mycobacterium Vaccae for Injection (Vaccae) from the SFDA (State Food and Drug Administration).

According to the approval documents, the product could be used as a biological product in Phase III clinical test for the prevention of tuberculosis.

As a product independently-developed and sold by Zhifei Biological, Vaccae could be used as adjuvant drug for the chemotherapy of tuberculosis. The product generated income of CNY 36.64 million, CNY 46.01 million and CNY 41.36 million in 2010, 2011 and the first three quarters of 2012, respectively, with an average gross profit margin of about 89.24%.

According to the 2012 global tuberculosis report issued by the WHO (World Health Organization), a total of 13 vaccines for the prevention of tuberculosis in the world have entered clinical research stage and only India鈥檚 M.indicus pranii (MIP),which is still being developed, has entered Phase III clinical test stage. According to Zhifei Biological, the approval of the Vaccae to be used in Phase III clinical test means China has caught up with other countries in the study in this field.

Click here for the complete issue.

EDITORS' CHOICE  

Credits to: American Chemical Society
COLUMNS  

APBN Editorial Calendar 2015
Trends and Predictions for 2015 Robotics in Healthcare Nutrition Universal Health Coverage
Start-Up Biotech Companies Preventative and Translational Medicine Biofuels ASEAN Economic Community and Asia's Life Sciences Industry
Big Data: Healthcare and Drug Development Antibody Engineering in Japan Christmas Edition
APBN Editorial Calendar 2016
Korea's Biotechnology Industry Nutrition and Allergies: Are we, Too Clean? Medical Devices and Technology: Innovation that leaves an Inspiration Tobacco Smoking: The 'Real' Cost of One Cigarette
Life-Saving Opportunities: A Guide to Regenerative Medicine Occupational Health Water Technology Olympics: Evolution of Sports
Respiratory: Seasonal flu viruses
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy